Calyx ACTIVATEs CRO Partnership Program
Calyx has announced a new partnership program for Clinical Research Organizations (CROs). The program, “ACTIVATE Solutions for CRO Partners,” is designed to provide alignment between Calyx and its CRO partners.
Those who qualify to participate in ACTIVATE operate under a personalized governance and reporting structure that provides access to technology, decision-making, and issue resolution aiming to generate faster trial execution.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025